Introductory Editorial: Tyrosine Kinases in Cancer
Olga Blau, Boris Vladimirovich Afanasyev, Igor Wolfgang Blau
Abstract
Open-access reader
Olga Blau, Boris Vladimirovich Afanasyev, Igor Wolfgang Blau
Abstract
Open-access reader
Articles should focus on tyrosine kinases in cancer and may include the following topics: Tyrosine kinases. § § Includes both tyrosine kinases and receptor tyrosine kinases, roles, including extracellular and intracellular signaling cascades. Aberrant tyrosine kinases § § Abnormalities including point mutations, chromosomal translocations and downstream effects of constitutive activation. Disease § § Roles in cancer, including solid and haematological malignancies, the use of tyrosine kinase inhibitors (TKIs) and resistance to TKIs. This supplement is intended to focus on tyrosine kinases in cancer. Aberrant tyrosine kinases and disease are included within the supplement’s scope.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Articles should focus on tyrosine kinases in cancer and may include the following topics: Tyrosine kinases. § § Includes both tyrosine kinases and receptor tyrosine kinases, roles, including extracellular and intracellular signaling cascades. Aberrant tyrosine kinases § § Abnormalities including point mutations, chromosomal translocations and downstream effects of constitutive activation. Disease § § Roles in cancer, including solid and haematological malignancies, the use of tyrosine kinase inhibitors (TKIs) and resistance to TKIs. This supplement is intended to focus on tyrosine kinases in cancer. Aberrant tyrosine kinases and disease are included within the supplement’s scope.
Key concepts: Receptor tyrosine kinase, Tyrosine kinase, Kinase, Cancer research, ROR1, SH3 domain, Protein tyrosine phosphatase, Tyrosine